Evidence map›Paper›PMID 42716788›Full record

ArticleLife science alliance2026

Proximity labeling puts ZFP36L1 as central hub for posttranscriptional regulation networks in T cells.

Anouk P Jurgens, Branka Popović, Floris Pj van Alphen, Maxime Steinmetz, Leyma Wardak, Antonia Bradarić, Sander Engels, Carmen van der Zwaan, Maartje van den Biggelaar, Arie J Hoogendijk and 2 more

Abstract read
In one paragraph

Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anouk P JurgensDepartment of Research, T cell Differentiation Lab, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID https://orcid.org/0009-0001-7118-229X
Branka PopovićDepartment of Research, T cell Differentiation Lab, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Floris Pj van AlphenDepartment of Research, Bleeding & Hemostasis, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Maxime SteinmetzDepartment of Research, T cell Differentiation Lab, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Leyma WardakDepartment of Research, T cell Differentiation Lab, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Antonia BradarićDepartment of Research, T cell Differentiation Lab, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Sander EngelsDepartment of Research, T cell Differentiation Lab, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Carmen van der ZwaanDepartment of Research, Bleeding & Hemostasis, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Maartje van den BiggelaarDepartment of Research, Bleeding & Hemostasis, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0001-6970-5496
Arie J HoogendijkDepartment of Research, Bleeding & Hemostasis, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.
Julien BéthuneDepartment of Biotechnology, HAW Hamburg, Germany.
Monika C WolkersDepartment of Research, T cell Differentiation Lab, Sanquin Blood Supply Foundation, Amsterdam, Netherlands m.wolkers@sanquin.nl.ORCID https://orcid.org/0000-0003-3242-1363

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective T cell responses against pathogens require a rapid yet tightly controlled remodeling of the proteome, and RNA binding proteins (RBPs) are key in this process. For instance, the RBP ZFP36L1 prevents excessive protein production and thereby limits immunopathology. ZFP36L1 is primarily known to mediate mRNA decay, but it can also regulate other processes. How its mode of action relates to its interaction partners is, however, not well-understood. Here, we mapped the ZFP36L1 interactome in primary human T cells. Using proximity labeling, we identified known and new interactors that regulate 3'UTR-mediated RNA degradation, deadenylation, stress granule/p-body formation, as well as 5'UTR-mediated translation repression and mRNA decapping. Snapshot analysis uncovered the ZFP36L1 interactome dynamics and RNA (in)dependency throughout T cell activation. Intriguingly, proximity labeling also uncovered regulators of ZFP36L1 protein expression. This included the helicase UPF1, which not only interacts with ZFP36L1 protein but that may also promote its protein expression. Altogether, this comprehensive interactome map underlines the versatility of interactions with ZFP36L1 and their possible role in cellular function.

Indexed as

Butyrate Response Factor 1T-Lymphocytes3' Untranslated RegionsGene Expression RegulationHumansLymphocyte ActivationProtein BindingRNA-Binding ProteinsRNA, MessengerRNA Stability3' Untranslated RegionsButyrate Response Factor 1RNA-Binding ProteinsRNA, MessengerZFP36L1 protein, human

Identifiers

PMID42716788
PMCPMC13558869

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.